Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
2024-04-25 21:41
GSK Advocates Importance of Adult Immunisation amongst Malaysians
2024-04-25 14:53
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19
2024-04-22 19:52
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
2024-04-22 09:00
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
2024-04-22 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
2024-04-19 21:00
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
2024-04-19 13:17
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
2024-04-19 10:54
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
2024-04-18 20:00
TaiGen Successfully Completes TG-1000 Phase III Study
2024-04-18 11:03
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
2024-04-17 14:03
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA
2024-04-17 11:22
Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting
2024-04-16 22:00
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
2024-04-16 20:00
Exploring Pioneering Programs in Medical Integration in the Greater Bay Area: Actively Applying Digital Identity and Global Legal Entity Identifier (LEI)
2024-04-16 19:05
Asian Plastics & Rubber Industry Online Exhibition 2024 Grand Opening
2024-04-16 14:59
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
2024-04-15 13:06
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG
2024-04-15 12:22
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
2024-04-09 20:00
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China
2024-04-08 22:00
1
2
3
4
5
226